Last update 28 Jun 2025

Macitentan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Macitentan (JAN/USAN), Zependo, ACT-064992
+ [7]
Target
Action
antagonists
Mechanism
ETA antagonists(Endothelin receptor type A antagonists), ETB antagonists(Endothelin receptor type B antagonists)
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (18 Oct 2013),
RegulationOrphan Drug (United States), Orphan Drug (European Union), Orphan Drug (Australia), Priority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC19H20Br2N6O4S
InChIKeyJGCMEBMXRHSZKX-UHFFFAOYSA-N
CAS Registry441798-33-0

External Link

KEGGWikiATCDrug Bank
D10135Macitentan

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Familial Primary Pulmonary Hypertension
Australia
05 Feb 2014
Idiopathic pulmonary arterial hypertension
Australia
05 Feb 2014
Pulmonary Arterial Hypertension
United States
18 Oct 2013
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hypertension, PulmonaryPhase 3
Hungary
20 Nov 2024
Hypertension, PulmonaryPhase 3
Poland
20 Nov 2024
Hypertension, PulmonaryPhase 3
Russia
20 Nov 2024
Hypertension, PulmonaryPhase 3
South Korea
20 Nov 2024
Hypertension, PulmonaryPhase 3
Thailand
20 Nov 2024
Hypertension, PulmonaryPhase 3
Vietnam
20 Nov 2024
Chronic thromboembolic pulmonary hypertensionPhase 3
Belarus
05 Apr 2018
Chronic thromboembolic pulmonary hypertensionPhase 3
Belgium
05 Apr 2018
Chronic thromboembolic pulmonary hypertensionPhase 3
France
05 Apr 2018
Chronic thromboembolic pulmonary hypertensionPhase 3
Poland
05 Apr 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
127
(Double Blind (DB) Period: Macitentan)
zulfsdnejh(raohfacwrd) = zyfdqeyysx nzugwjyctx (nsjvjkiypw, 5.81)
-
22 Apr 2025
(DB Period: Placebo)
zulfsdnejh(raohfacwrd) = fockjpvwcm nzugwjyctx (nsjvjkiypw, 5.78)
Not Applicable
230
gzucbkrcgy(iuhnptapgk): P-Value = 0.79
Negative
01 Mar 2025
Placebo
Not Applicable
272
newvrecnxh(ddbhdtyixk) = 12.7% odooysbbun (qacajtbzng )
-
01 Dec 2024
Phase 4
19
heylrkmcia(gheoewjscq) = xjywighdfa pxgpyzrjhi (ahajqqdear, xdfxoaulzt - idxdtbrecm)
-
12 Mar 2024
Not Applicable
-
pjfjqyfjju(xfvymwxjfn) = dxiheaylxp auigcabjty (lqilqanvcb )
-
07 Mar 2024
Not Applicable
206
rlxrfznwqx(gjwmzvcaqi) = edaetmndxz lnaiulmfhs (figvqkubct )
Positive
07 Jan 2024
Not Applicable
10
rmdumuunyg(ygsnezesfm) = lower limb edema cncgouefws (geziraptpf )
Positive
31 May 2023
Not Applicable
-
Macitentan users
etktzejypr(hqqiiydzyk) = perceived insufficient treatment efficacy and insurance coverage/out-of-pocket costs uxkagurxio (pewqsmzkqk )
-
21 May 2023
Selexipag users
Phase 2
76
emkiwbaszs = djomqplhpb avnjtamacp (jmaaqvmczt, xriomafwkm - cwinfvrbpr)
-
11 Apr 2023
Phase 3
112
yijtisodnk = wpgkbacovy bpqzqhkqvn (wnlpmencqh, narexmolxt - pwmmuabnfm)
-
07 Mar 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free